Latest News & Features
Americas
The US District Court for the District of Delaware has dismissed a dispute between Apotex and Allergan after the companies entered into a settlement agreement. 28 April 2017
Biotechnology
Merck will divest its biosimilars business to Fresenius Kabi in order to focus on innovative drugs. 28 April 2017
Americas
The US Supreme Court heard oral arguments from Amgen and Sandoz yesterday in the ongoing battle over a biosimilar version of Amgen’s Neupogen. 27 April 2017
Americas
The US Court of Appeals for the Federal Circuit has partly affirmed, partly reversed and partly vacated a dispute between Duke University, based in North Carolina, and biotech company BioMarin Pharmaceutical. 27 April 2017
Americas
Merck and PDL Biopharma have settled a dispute over Merck’s cancer drug Keytruda (pembrolizumab), which allegedly infringed a patent belonging to PDL. 27 April 2017
Americas
LSIPR and law firm HGF held a webinar yesterday focusing on CRISPR and how to navigate the IP landscape. 26 April 2017
Americas
The US Supreme Court will hear oral arguments from Sandoz and Amgen tomorrow, when the battle over a biosimilar of Amgen’s Neupogen will resume. 25 April 2017
Americas
Eli Lilly must pay Germany-based pharmaceutical company Erfindergemeinschaft UroPep $20 million for patent infringement. 25 April 2017
Americas
Momenta Pharmaceuticals and Sandoz have filed a motion to dismiss competition allegations made by Amphastar Pharmaceuticals. 24 April 2017
Americas
Eli Lilly has sued Par Pharmaceutical for patent infringement over the drug Axiron (testosterone), used to treat men with low or no testosterone. 24 April 2017